Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jean-Philippe Collet

Showing results (251-260 of 376) with videos related to

Pageof 38
Sort By:
Presse Medicale (Paris, France : 1983)|July 26, 2015
[From FRANCE 2 to FRANCE TAVI: are indications, technique and results of transcatheter aortic valve replacement the same?]Vincent Auffret, Marc Bedossa, Dominique Boulmier, et al.
Archives of Cardiovascular Diseases|August 17, 2024
Ten-year trends in characteristics, management and outcomes of patients admitted with cardiogenic shock in the ACTION-SHOCK cohortDavid Sulman, Frederic Beaupré, Perrine Devos, et al.
Journal of the American College of Cardiology|August 29, 2018
Long-Term Mortality and Early Valve Dysfunction According to Anticoagulation Use: The FRANCE TAVI RegistryPavel Overtchouk, Paul Guedeney, Stéphanie Rouanet, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|January 14, 2023
Antithrombotic therapy and cardiovascular outcomes after transcatheter aortic valve implantation in patients without indications for chronic oral anticoagulation: a systematic review and network meta-analysis of randomized controlled trialsPaul Guedeney, Vincent Roule, Jules Mesnier, et al.
Journal of the American College of Cardiology|December 24, 2013
Impact of red blood cell transfusion on platelet aggregation and inflammatory response in anemic coronary and noncoronary patients: the TRANSFUSION-2 study (impact of transfusion of red blood cell on platelet activation and aggregation studied with flow cytometry use and light transmission aggregometry)Johanne Silvain, Jérémie Abtan, Mathieu Kerneis, et al.
Journal of the American College of Cardiology|August 31, 2020
Interleukin-1β and Risk of Premature Death in Patients With Myocardial InfarctionJohanne Silvain, Mathieu Kerneis, Michel Zeitouni, et al.
Circulation. Cardiovascular Interventions|October 15, 2019
Investigator Versus Core Laboratory Evaluation of Coronary Flow and Related Mortality in the CULPRIT-SHOCK TrialMichel Zeitouni, Olivier Barthélémy, Marie Hauguel-Moreau, et al.
Journal of the American College of Cardiology|March 2, 2019
Interval From Initiation of Prasugrel to Coronary Angiography in Patients With Non-ST-Segment Elevation Myocardial InfarctionJohanne Silvain, Tomasz Rakowski, Benoit Lattuca, et al.
JACC. Cardiovascular Interventions|August 25, 2022
Supraventricular Arrhythmia Following Patent Foramen Ovale Percutaneous ClosurePaul Guedeney, Mikael Laredo, Michel Zeitouni, et al.
European Journal of Clinical Pharmacology|July 12, 2014
Prasugrel but not high dose clopidogrel overcomes the lansoprazole neutralizing effect of P2Y12 inhibition: Results of the randomized DOSAPI studyJean-Philippe Collet, Jean-Sébastien Hulot, Jérémie Abtan, et al.
Pageof 38

Showing results (251-260 of 376) with videos related to

Sort By:
Pageof 38
Presse Medicale (Paris, France : 1983)|July 26, 2015
[From FRANCE 2 to FRANCE TAVI: are indications, technique and results of transcatheter aortic valve replacement the same?]Vincent Auffret, Marc Bedossa, Dominique Boulmier, et al.
Archives of Cardiovascular Diseases|August 17, 2024
Ten-year trends in characteristics, management and outcomes of patients admitted with cardiogenic shock in the ACTION-SHOCK cohortDavid Sulman, Frederic Beaupré, Perrine Devos, et al.
Journal of the American College of Cardiology|August 29, 2018
Long-Term Mortality and Early Valve Dysfunction According to Anticoagulation Use: The FRANCE TAVI RegistryPavel Overtchouk, Paul Guedeney, Stéphanie Rouanet, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|January 14, 2023
Antithrombotic therapy and cardiovascular outcomes after transcatheter aortic valve implantation in patients without indications for chronic oral anticoagulation: a systematic review and network meta-analysis of randomized controlled trialsPaul Guedeney, Vincent Roule, Jules Mesnier, et al.
Journal of the American College of Cardiology|December 24, 2013
Impact of red blood cell transfusion on platelet aggregation and inflammatory response in anemic coronary and noncoronary patients: the TRANSFUSION-2 study (impact of transfusion of red blood cell on platelet activation and aggregation studied with flow cytometry use and light transmission aggregometry)Johanne Silvain, Jérémie Abtan, Mathieu Kerneis, et al.
Journal of the American College of Cardiology|August 31, 2020
Interleukin-1β and Risk of Premature Death in Patients With Myocardial InfarctionJohanne Silvain, Mathieu Kerneis, Michel Zeitouni, et al.
Circulation. Cardiovascular Interventions|October 15, 2019
Investigator Versus Core Laboratory Evaluation of Coronary Flow and Related Mortality in the CULPRIT-SHOCK TrialMichel Zeitouni, Olivier Barthélémy, Marie Hauguel-Moreau, et al.
Journal of the American College of Cardiology|March 2, 2019
Interval From Initiation of Prasugrel to Coronary Angiography in Patients With Non-ST-Segment Elevation Myocardial InfarctionJohanne Silvain, Tomasz Rakowski, Benoit Lattuca, et al.
JACC. Cardiovascular Interventions|August 25, 2022
Supraventricular Arrhythmia Following Patent Foramen Ovale Percutaneous ClosurePaul Guedeney, Mikael Laredo, Michel Zeitouni, et al.
European Journal of Clinical Pharmacology|July 12, 2014
Prasugrel but not high dose clopidogrel overcomes the lansoprazole neutralizing effect of P2Y12 inhibition: Results of the randomized DOSAPI studyJean-Philippe Collet, Jean-Sébastien Hulot, Jérémie Abtan, et al.
Pageof 38